Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

673 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Science in Focus: The Microbiome and Cancer Therapy.
Alexander JL, Kohoutova D, Powell N. Alexander JL, et al. Among authors: powell n. Clin Oncol (R Coll Radiol). 2019 Jan;31(1):1-4. doi: 10.1016/j.clon.2018.09.004. Epub 2018 Oct 6. Clin Oncol (R Coll Radiol). 2019. PMID: 30301591 No abstract available.
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N; Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group. Alexander JL, et al. Among authors: powell n. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-224. doi: 10.1016/S2468-1253(21)00024-8. Epub 2021 Jan 26. Lancet Gastroenterol Hepatol. 2021. PMID: 33508241 Free PMC article. Review.
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
Alexander JL, Powell N; British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group. Alexander JL, et al. Among authors: powell n. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):528-529. doi: 10.1016/S2468-1253(21)00184-9. Epub 2021 May 26. Lancet Gastroenterol Hepatol. 2021. PMID: 34048723 Free PMC article. No abstract available.
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.
Alexander JL, Kennedy NA, Lees CW, Ahmad T, Powell N; British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group. Alexander JL, et al. Among authors: powell n. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):523-524. doi: 10.1016/S2468-1253(21)00194-1. Lancet Gastroenterol Hepatol. 2021. PMID: 34119033 Free PMC article. No abstract available.
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
Alexander JL, Ibraheim H, Sheth B, Little J, Khan MS, Richards C, Hunter N, Chauhan D, Ratnakumaran R, McHugh K, Pinato DJ, Nathan P, Choy J, Crusz SM, Furness A, Turajlic S, Pickering L, Larkin J, Teare JP, Papa S, Speight A, Sharma A, Powell N. Alexander JL, et al. Among authors: powell n. J Immunother Cancer. 2021 Jul;9(7):e002742. doi: 10.1136/jitc-2021-002742. J Immunother Cancer. 2021. PMID: 34233964 Free PMC article.
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Alexander JL, Selinger CP, Powell N; British Society of Gastroenterology Inflammatory Bowel Disease section and the Inflammatory Bowel Disease Clinical Research Group. Alexander JL, et al. Among authors: powell n. Lancet Gastroenterol Hepatol. 2021 Dec;6(12):987-988. doi: 10.1016/S2468-1253(21)00374-5. Epub 2021 Oct 13. Lancet Gastroenterol Hepatol. 2021. PMID: 34653395 Free PMC article. No abstract available.
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study.
Alexander JL, Kennedy NA, Ibraheim H, Anandabaskaran S, Saifuddin A, Castro Seoane R, Liu Z, Nice R, Bewshea C, D'Mello A, Constable L, Jones GR, Balarajah S, Fiorentino F, Sebastian S, Irving PM, Hicks LC, Williams HRT, Kent AJ, Linger R, Parkes M, Kok K, Patel KV, Teare JP, Altmann DM, Boyton RJ, Goodhand JR, Hart AL, Lees CW, Ahmad T, Powell N; VIP study investigators. Alexander JL, et al. Among authors: powell n. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):342-352. doi: 10.1016/S2468-1253(22)00005-X. Epub 2022 Feb 4. Lancet Gastroenterol Hepatol. 2022. PMID: 35123676 Free PMC article.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Lin S, Kennedy NA, Saifuddin A, Sandoval DM, Reynolds CJ, Seoane RC, Kottoor SH, Pieper FP, Lin KM, Butler DK, Chanchlani N, Nice R, Chee D, Bewshea C, Janjua M, McDonald TJ, Sebastian S, Alexander JL, Constable L, Lee JC, Murray CD, Hart AL, Irving PM, Jones GR, Kok KB, Lamb CA, Lees CW, Altmann DM, Boyton RJ, Goodhand JR, Powell N, Ahmad T; CLARITY IBD study. Lin S, et al. Among authors: powell n. Nat Commun. 2022 Mar 16;13(1):1379. doi: 10.1038/s41467-022-28517-z. Nat Commun. 2022. PMID: 35296643 Free PMC article.
673 results